跳轉至內容
Merck
  • Cyclic hypoxia does not alter RAD51 expression or PARP inhibitor cell kill in tumor cells.

Cyclic hypoxia does not alter RAD51 expression or PARP inhibitor cell kill in tumor cells.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology (2015-04-07)
Ramya Kumareswaran, Naz Chaudary, Karolina Jaluba, Alice Meng, Jenna Sykes, Asm Borhan, Richard P Hill, Robert G Bristow
摘要

Solid tumors contain regions of chronic and cyclic hypoxia. Chronic hypoxia can downregulate RAD51 and sensitize cells to PARP inhibition. Herein, we show that RAD51 expression, cell survival and toxicity to PARP inhibition is not affected under cyclic hypoxic conditions. This suggests that PARP inhibition may be selectively toxic in tumor sub-regions associated with chronic hypoxia.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
碘化丙啶, ≥94.0% (HPLC)
Sigma-Aldrich
碘化丙啶 溶液
Sigma-Aldrich
二喹啉甲酸 二钠盐 水合物, ≥98% (HPLC)